ATE355360T1 - Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung - Google Patents

Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung

Info

Publication number
ATE355360T1
ATE355360T1 AT97945702T AT97945702T ATE355360T1 AT E355360 T1 ATE355360 T1 AT E355360T1 AT 97945702 T AT97945702 T AT 97945702T AT 97945702 T AT97945702 T AT 97945702T AT E355360 T1 ATE355360 T1 AT E355360T1
Authority
AT
Austria
Prior art keywords
strain
lactobacillus acidophilus
lactic ferment
special strain
ferment containing
Prior art date
Application number
AT97945702T
Other languages
English (en)
Inventor
Francois-Marie Luquet
Original Assignee
Bio K & Internat Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio K & Internat Inc filed Critical Bio K & Internat Inc
Application granted granted Critical
Publication of ATE355360T1 publication Critical patent/ATE355360T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
AT97945702T 1996-11-29 1997-11-28 Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung ATE355360T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3215796P 1996-11-29 1996-11-29

Publications (1)

Publication Number Publication Date
ATE355360T1 true ATE355360T1 (de) 2006-03-15

Family

ID=21863414

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97945702T ATE355360T1 (de) 1996-11-29 1997-11-28 Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung

Country Status (8)

Country Link
US (1) US6607905B1 (de)
EP (2) EP0951531B1 (de)
AT (1) ATE355360T1 (de)
AU (1) AU5113798A (de)
CA (1) CA2271930C (de)
DE (1) DE69737420T2 (de)
ES (1) ES2283027T3 (de)
WO (1) WO1998023727A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
GB2338245B (en) 1997-08-21 2001-11-21 New Zealand Dairy Board Immunity enhancing lactic acid bacteria
ATE290391T1 (de) * 1998-12-11 2005-03-15 Urex Biotech Inc Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
ES2155783B1 (es) * 1999-05-07 2002-05-16 Danone Sa Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
ES2155782B1 (es) * 1999-05-07 2002-05-16 Danone Sa Utilizacion de bacterias acidolacticas pra preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos.
PT1178730E (pt) * 1999-05-07 2005-06-30 Gervais Danone Sa Utilizacao de bacterias do acido lactico na preparacao de leites fermemntados para o tratamento de niveis de imunidade deprimidos
CA2374938A1 (en) * 1999-05-25 2000-11-30 Gregor Reid Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices
CA2374937A1 (en) * 1999-05-25 2000-11-30 Gregor Reid Oral administration of lactobacillus for the maintenance of health in women
JP2003535903A (ja) * 2000-06-19 2003-12-02 ミューコプロテック・プロプライエタリー・リミテッド プロバイオティックを用いた、粘膜表面での細菌またはウイルス感染の免疫療法または治療、およびそのための組成物
ES2169675B1 (es) * 2000-07-19 2003-04-16 Danone Sa Producto con propiedades antiinflamatorias para el colon humano.
CA2364249A1 (fr) 2001-11-27 2003-05-27 Unknown-Inconnu Effet de bacteries lactiques sur l'apoptose cellulaire de tumeur
PL212647B1 (pl) 2002-03-21 2012-11-30 Bifodan As Kompozycja farmaceutyczna, szczep Lactobacillus paracasei Lbp PB01 oraz szczep Lactobacillus paracasei Lbp PB01 w polaczeniu ze szczepem Lactobacillus acidophilus Lba EB01, produkt chlonny zawierajacy te kompozycje oraz produkt nabialowy, produkt nutraceutyczny i czynnosciowy produkt zywnosciowy zawierajace ten szczep albo te dwa szczepy, a takze zastosowanie tego szczepu albo tych dwóch szczepów
CN1317385C (zh) * 2003-05-30 2007-05-23 上海光明乳业股份有限公司 干酪乳杆菌Bd－II菌株及其在降低血脂方面的应用
CA2448843A1 (fr) * 2003-11-13 2005-05-13 Bio-K Plus International Inc. Effets de differents surnageants de bacteries lactiques de bio-k plus sur des lignees cellulaires endotheliales
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
CA2470090A1 (fr) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
ATE512211T1 (de) 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
ES2607988T3 (es) 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
US20110165127A1 (en) * 2006-06-09 2011-07-07 Fabiola Masri Dairy-derived probiotic compositions and uses thereof
AU2013201783B2 (en) * 2006-10-02 2015-06-04 International N&H Denmark Aps Probiotics for use in reducing the incidence and duration of illness
AU2007302715B2 (en) * 2006-10-02 2013-01-31 International N&H Denmark Aps Probiotics for use in reducing the incidence and duration of illness
US20130011374A1 (en) * 2006-12-22 2013-01-10 Bio-K Plus International Inc. Growth inhibition of microorganisms by lactic acid bacteria
ES2373411T3 (es) * 2006-12-22 2012-02-03 Bio-K Plus International Inc. Inhibición del crecimiento y eliminación del staphylococcus aureus resistente a la meticilina por bacterias ácido lácticas.
ES2551719T3 (es) 2007-02-01 2015-11-23 Iams Europe B.V. Procedimiento para disminuir la inflamación y el estrés en un mamífero usando antimetabolitos de glucosa, aguacate o extractos de aguacate
CN101250493B (zh) * 2008-04-01 2010-06-02 浙江省农业科学院 固、液二步发酵工艺生产饲用嗜酸乳杆菌的方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CL2009001511A1 (es) * 2009-07-02 2009-10-23 Univ De Concepcion 61 02% Formulacion farmaceutica que comprende cepas viables de lactobacillus acidophilus lpv 31 y l. plantarum lpm-01, la cual es util en la prevencion y/o tratamiento de infecciones urinarias y en mejorar la respuesta inmune en pacientes inmunocopromentidos.
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CA2915979C (en) 2013-06-27 2021-06-08 Starbucks Corporation D/B/A Starbucks Coffee Company Biopreservation methods for beverages and other foods
AT517321A1 (de) * 2015-06-10 2016-12-15 Trodat Gmbh Stempel
WO2023066973A1 (en) * 2021-10-19 2023-04-27 Kerry Group Services International Limited Probiotic strains for reducing blood cholesterol and/or treating dyslipidemia, and methods for using and producing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61109729A (ja) * 1984-11-05 1986-05-28 Advance Res & Dev Co Ltd コレステロ−ル低下剤
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
ES2111625T3 (es) * 1992-07-06 1998-03-16 Nestle Sa Agente antigastritis.
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌

Also Published As

Publication number Publication date
EP0951531B1 (de) 2007-02-28
DE69737420T2 (de) 2007-11-15
DE69737420D1 (de) 2007-04-12
EP0951531A1 (de) 1999-10-27
US6607905B1 (en) 2003-08-19
EP2159277A1 (de) 2010-03-03
WO1998023727A1 (en) 1998-06-04
CA2271930A1 (en) 1998-06-04
ES2283027T3 (es) 2007-10-16
CA2271930C (en) 2006-10-17
AU5113798A (en) 1998-06-22

Similar Documents

Publication Publication Date Title
ATE355360T1 (de) Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung
RU93049638A (ru) Молочно-кислая бактерия
DE69535290D1 (de) Herstellung von durch streptococcus thermophilus fermentierten produkten mit hohem gehalt von galacto-oligosacchariden und beta-galactosidase
DE69224814D1 (de) Den darm kolonisierende laktobacillen
MXPA04000808A (es) Cepas probioticas de lactobacillus salivarius.
EP1754789A3 (de) Bacillus-Stämme und Pestizid-Proteine
FR12C0065I1 (de)
DK0506817T3 (da) Farmaceutisk præparat til kontrol med patogene intestinale bakterier
HUT39480A (en) Process for preparing antibiotic complex a 40926 and pure components thereof i.e. factors pa, pb, a, b and b down o
ATE248216T1 (de) Ersatztherapie für zahnkaries
DE69030326D1 (de) Zubereitung mit ligninabbauender aktivität, verfahren zu deren herstellung und anwendungen dafür
EP0486024A3 (en) Lactobacillus sp.b001 and method of producing mannitol, acetic acid and lactic acid
EP0486067A3 (en) Peroxidase gene of microbial origin
ATE291353T1 (de) Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
EP0304897A3 (de) Mittel zur Immunisierung des menschlichen Körpers bei HIV-Infektionen
AU3846595A (en) Doubly virus-inactivated human blood plasma, blood plasma derivatives produced therefrom and method for their production
SE9201006D0 (sv) Delignifying preparation exhibiting alpha-l-arabino -furanosidase activity, production and application thereof
DE69225039D1 (de) Mikroorganismen und Verfahren zur Herstellung von 3-Alpha, 7-Alpha-Dihydroxy-12-Keto-Cholansäure
IT9047536A0 (it) Ceppo di batteri lactobacillus casei subsp. casei 37 per la produzione di un preparato biologico batteriale.
RU94022337A (ru) Штамм бактерий proteus mirabilis - продуцент термолабильного энтеротоксина

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0951531

Country of ref document: EP

REN Ceased due to non-payment of the annual fee